Company Filing History:
1 out of 1,566 
1 out of 10 
Years Active: 2021
Title: Innovator Spotlight: Wan Beom Park
Introduction: Wan Beom Park, based in Seoul, South Korea, is an accomplished inventor known for his significant contribution to the field of medicine through his patent related to infectious diseases. His research focuses on severe fever with thrombocytopenia syndrome, a viral illness that poses a critical health threat.
Latest Patents: Wan Beom Park holds a patent for an antibody that binds to the envelope glycoprotein of the severe fever with thrombocytopenia syndrome virus (SFTSV). This innovative antibody is instrumental in effectively detecting and diagnosing SFTSV and treating severe fever with thrombocytopenia syndrome. His work is vital for advancing medical diagnostics and therapeutics surrounding this virus.
Career Highlights: Wan Beom Park has made substantial strides in his career, primarily through his associations with prestigious research institutions. He has worked with the Seoul National University R&D Foundation and Institut Pasteur Korea, where he contributed to cutting-edge research and development projects aimed at addressing public health challenges.
Collaborations: Throughout his career, Wan Beom Park has collaborated with notable colleagues, including Junho Chung and Ki-Hyun Kim. These partnerships have propelled numerous research initiatives forward, fostering innovation and enhancing our understanding of viral pathogenesis.
Conclusion: Wan Beom Park exemplifies dedication to scientific advancement and public health through his innovative work on SFTSV. His patent is a testament to his expertise and commitment to improving diagnostic and therapeutic strategies in medicine. The impact of his research reflects the importance of innovation in tackling global health challenges.